Navigation Links
Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, July 03, 2007 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd , a leading microRNA company, announced today that J. Michael French, Rosetta Genomics President, will present at CE Unterberg, Towbin Emerging Growth Opportunities Conference on Tuesday, July 10, at 11:00 am EST at the Mandarin Oriental Hotel in New York.

A live audio webcast of the presentation will be available on the "Investors" section of the company's website, www.RosettaGenomics.com. A replay of the presentation will be available for 30 days after the conference.

About Rosetta Genomics

Rosetta Genomics is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and infectious diseases. For more information please visit: www.rosettagenomics.com

    Contact: Media


    Alan Zachary

    T: +1-312-944-6784

    


    Investors

    Juliane Snowden

    T: +1-212-213-0006
media@rosettagenomics.com investors@rosettagenomics.com

CONTACT: Contact: Media: Alan Zachary, T: +1-312-944-6784,; Investors, Juliane Snowden, T: +1-212-213-0006, '"/>




Page: 1 2

Related medicine technology :

1. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
2. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
4. Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow
5. Isis Pharmaceuticals Announces Its Participation at the Upcoming ACC 56th Annual Scientific Session in New Orleans and Its Live Analyst/Investor Webcast Presentation
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
9. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting

Post Your Comments:
(Date:11/25/2009)...5/PRNewswire/--TheFDAgrantedtraditionalapprovalfor...reversetranscriptaseinhibitor(NNRTI).INTELENCEisth...xperiencedadultswhoareexperiencingvirologicfailure...oviral(ARV)agents.Thetraditionalapprovalisbasedon4...-2.INTELENCEiscurrentlymarketedintheU.S.byTibotecT...
(Date:11/25/2009)...ov.25/PRNewswire/--AMPACFineChemicalsLLC(AFC),asub...announcedtodaythatitreceivedtheEnvironmentalRespon...EnvironmentalSummit,sponsoredbytheCaliforniaManufa...lEnvironmentalAssociation(IEA)andtheChemicalIndust...emostprestigiousawardavailablefromallthreeorganiza...
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...tatesDentalDevicesMarketAnalysisandForecaststo2015...ed-States-Dental-Devices-Market-Analysis-and-Forec...MarketAnalysisandForecaststo2015 ,, Summary ,...mationanddatarelatingtotheUSdentaldevicesmarket.It...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12REMOXY 28R 29 NDA Update 50869 1REMOXY 28R 29 NDA Update 50869 2REMOXY 28R 29 NDA Update 50869 3REMOXY 28R 29 NDA Update 50869 4New Software Makes Lawyers Accountable for Their Part in Our Healthcare Crisis 50866 1New Software Makes Lawyers Accountable for Their Part in Our Healthcare Crisis 50866 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 1AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 3AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 4
...e American Heart Association Scientific Sessions ...OCA RATON, Fla., Nov. 7 Nabi,Biopharmaceuticals (...pletion,of its Phase 2b trial of NicVAX(R) (Nicoti...d proprietary investigational vaccine being,develo...g relapse. The,final 12-month data confirm the hig...
...asense(R) in melanoma opens to global accrual ...ne disease - Named-patient/compassionate-use p...o review FDA decision on Genasense in CLL, - Brief...d in new clinical ...rporated (Nasdaq: GNTA ) today reported financial...
Other Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Genta Incorporated Announces Third Quarter 2007 Financial Results 2Genta Incorporated Announces Third Quarter 2007 Financial Results 3Genta Incorporated Announces Third Quarter 2007 Financial Results 4Genta Incorporated Announces Third Quarter 2007 Financial Results 5Genta Incorporated Announces Third Quarter 2007 Financial Results 6Genta Incorporated Announces Third Quarter 2007 Financial Results 7
(Date:11/27/2009)...ire-USNewswire/--Preventingdiseaseisthegoalofevery...nesarebeingaddedtoassistindiseaseprevention.Butdoa...ifnot,whenareadditional,boostershots,neededtokeepi...s,theJournaloftheAmericanAcademyofPediatrics,Micha...chInstitute,basedatRochesterGeneralHospitalinRoche...
(Date:11/27/2009)...medical, economic burdens, study predicts , ...er of people with diabetes in the United States is...study predicts. , That would bring the total by...e, up from 23.7 million today. , , At the same t...l triple, the study also warns, rising from an est...
(Date:11/27/2009)...nteractive anatomy education apps from Modality an...sciences learning opportunities for iPhone and iPo...us) November 27, 2009 -- Modality, Inc. and Lipp... Wolters Kluwer Health, today announced the availa...App Store. Clemente’s Anatomy, Rohen’s...
(Date:11/26/2009)...an lead to strains or worse , , THURSDAY... wrong with stuffing your turkey full to bursting,...your suitcase as you pack for holiday trips. , ...S. hospital emergency rooms, doctors, offices, cli...ted injuries, such as muscle strains, pulls and te...
(Date:11/26/2009)...unications announces a highly effective and unconv...ggling to make an economic recovery. , ...rs is the type of challenge that could send ailing... Dr. David Benton, business growth expert and auth...dash; The Rfactor Intensive . “Fear is on...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...ed bird flu pandemic could claim as much as 140 mi...an researchers. // The authors of the report...ck McKibbin and fellow Australian National Univers...oduction. The report warned that developing ...
...a British millionaire currently living in Australi...children suffering from the worst form of attentio...vel method, space-age technology is usually used f...deficit hyperactivity disorder (ADHD) is a syndrom...
...firm LG Electronics has said that it will start to... a filter made from using an enzyme contained in t...//this enzyme will confer protection against the d...as fabricated after assessing the results of four ...
... an imminent deadline, labor unions are pushing Wa...are for its staff. // Although it appears that...rkers, and improve their lot, there appears more t...he scene at Washington is hotting up with the batt...
...ave the maximum number of cardiac patients by 2020...le at the earliest. // The above warning has been ... Stress, bad eating habits and the growing numb...rt diseases. 'Since heart disease is primari...
...provide a wide range of frozen Atlantic salmon and...by the elderly, single and those less gifted in th...ound that these frozen fish meals are missing out ...ther hoki or hake and does not give any choice to ...
Other Medicine News:Health News:Change In Lifestyle Recommended To Avoid Cardiac Disease 2
...SphygmoCor Px Central Blood Pressure Assessment an...ive method of obtaining central blood pressure and... enhance the treatment and management of patients....ction, the system derives the ascending aortic blo...
Genetic Systems HIV-1/HIV-2 PLUS O EIA (detects Ab to HIV-1 (M+O) and HIV-2)
Microspeed EC
Shandon High-Capacity Section Dryer
Medicine Products: